Search
Cag alpha
go.drugbank.com/bio_entities/BE0002850TargetHelicobacter pyloriPolypeptides: Cag alphaSynonyms: Cag-alfa, cag-alphaCilgavimab
go.drugbank.com/drugs/DB16393ApprovedInvestigational[L39411] EVUSHELD was granted marketing authorization by the EMA on March 28, 2022,[L41454] and was approved in Canada soon after, on April 14, 2022. … [A243351, A243361, L39411] Cilgavimab is not approved for any indication by the FDA.
Categories: tixagevimab and cilgavimab, Amino Acids, Peptides, and ProteinsSotagliflozin
go.drugbank.com/drugs/DB12713ApprovedInvestigational[L39734] A similar approval has also been sought in the US, but the FDA has since published a proposal to refuse the approval because the data submitted did not show that it was safe under the proposed … [L39705] Its potency in inhibiting SGLT2 is similar to that of other SGLT2 inhibitors, such as [canagliflozin] and [dapagliflozin], but its potency in inhibiting SGLT1 is >10-fold higher than its predecessors
Categories: Alimentary Tract and Metabolism, Drugs Used in DiabetesAcute Pelvic inflammatory disease
go.drugbank.com/conditions/DBCOND0022868Drugs: OfloxacinSynonyms: Acute pelvic inflammatory disease of the female pelvic organs and tissues, Acute pelvic inflammatory disease of the female pelvic organs AND/OR tissuesFacial Angiofibroma
go.drugbank.com/conditions/DBCOND0063101Drugs: SirolimusSynonyms: Angiokeratoma in tuberous sclerosisDysuria
go.drugbank.com/conditions/DBCOND0004536Synonyms: Difficulty in voiding, Difficulty in urinationDurvalumab
go.drugbank.com/drugs/DB11714ApprovedInvestigational[A192789,L12627] On March 27, 2020, durvalumab was approved by the FDA for use in combination with [etoposide] and either [carboplatin] or [cisplatin] as first-line treatment of patients with extensive-stage … [L12621] In September 2018, durvalumab was approved by the EMA for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), only if PD-L1 is expressed in
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsCoagulation factor VII human
go.drugbank.com/drugs/DB13150ApprovedInvestigationalCoagulation factor VII is human serine protease type enzyme that is involved in the extrinsic coagulation cascade which results in blood clotting.
Mixtures: OCTAPLEX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU, Octaplex Powder and Solvent for Solution for InfusionCategories: coagulation factor IX, II, VII and X in combination, Enzymes and CoenzymesPseudobulbar Affect (PBA)
go.drugbank.com/conditions/DBCOND0038672Synonyms: Pathological laughing and cryingPotassium alum
go.drugbank.com/drugs/DB09087ApprovedWithdrawn[L1070] It is an inorganic salt, also called potassium aluminum sulfate with a formula of AlK(SO4)2 that is predominantly produced in the dodecahydrate form (AlK(SO4)2 * 12H2O). … Potassium alum is formed by large, transparent crystals that are used in different products like food or drugs as a buffer, neutralizing or forming agent.[T60]
Mixtures: Gingibraid W Epineph and Alum 1e, Gingibraid W Epineph and Alum 2e